{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:51:06Z","timestamp":1786441866041,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,3,14]],"date-time":"2011-03-14T00:00:00Z","timestamp":1300060800000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1590\/s1807-59322011000100013","type":"journal-article","created":{"date-parts":[[2011,4,7]],"date-time":"2011-04-07T04:06:13Z","timestamp":1302149173000},"page":"73-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Fallopian tube origin of supposed ovarian high-grade serous carcinomas"],"prefix":"10.1016","volume":"66","author":[{"given":"Patricia Martini","family":"Diniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus Paula","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund Chada","family":"Baracat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena M","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1590\/S1807-59322011000100013_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"26","author":"Winter","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1590\/S1807-59322011000100013_bib2","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1590\/S1807-59322011000100013_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/00016340500324621","article-title":"Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention","volume":"85","author":"Sogaard","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1590\/S1807-59322011000100013_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.AOG.0000227787.24587.d1","article-title":"Clinical behavior of stage II\u2013IV low-grade serous carcinoma of the ovary","volume":"108","author":"Gershenson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1590\/S1807-59322011000100013_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1590\/S1807-59322011000100013_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9440(10)62549-7","article-title":"Diverse tumorigenic pathways in ovarian serous carcinoma","volume":"160","author":"Singer","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/path.1521","article-title":"In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours","volume":"202","author":"Sieben","year":"2004","journal-title":"J Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.01.013","article-title":"Precursors to pelvic serous carcinoma and their clinical implications","volume":"113","author":"Folkins","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1590\/S1807-59322011000100013_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1590\/S1807-59322011000100013_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1590\/S1807-59322011000100013_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncr.25450","article-title":"Bringing the p53 signature into focus","volume":"116","author":"Crum","year":"2010","journal-title":"Cancer"},{"key":"10.1590\/S1807-59322011000100013_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1055-3207(18)30276-X","article-title":"Fallopian tube carcinoma","volume":"7","author":"Nikrui","year":"1998","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1590\/S1807-59322011000100013_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/09513590.2010.487609","article-title":"Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy","volume":"26","author":"Gadducci","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.1590\/S1807-59322011000100013_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1590\/S1807-59322011000100013_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1590\/S1807-59322011000100013_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PAP.0b013e3181ecdee1","article-title":"A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube","volume":"17","author":"Mehrad","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"10.1590\/S1807-59322011000100013_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mehy.2008.06.028","article-title":"Is Chlamydia-infected tubal fimbria the origin of ovarian cancer?","volume":"71","author":"Carvalho","year":"2008","journal-title":"Med Hyp"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222015575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222015575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:04:09Z","timestamp":1761721449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222015575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1807593222015575"],"URL":"https:\/\/doi.org\/10.1590\/s1807-59322011000100013","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fallopian tube origin of supposed ovarian high-grade serous carcinomas","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1590\/S1807-59322011000100013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}